Indocyanine Green Tissue Perfusion Monitoring

CompletedOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

March 5, 2018

Primary Completion Date

June 28, 2018

Study Completion Date

July 1, 2018

Conditions
Regional Blood FlowWound Heal
Interventions
DIAGNOSTIC_TEST

fluorescence-mediated photoplethysmography

Indocyanine green dye (ICG) will be injected intravenously as a sterile solution at a dose of 0.5 mg/kg, and then imaging of skin will be done with a fluorescence camera. The ICG-angiogram sequence will consist of 1.5 x 2.0-cm field-of-view ICG fluorescence images acquired at the rate of approximately 30/sec during a period of about 15 seconds. Following acquisition of the initial transit angiogram sequence, several additional 15-second-long image sequences will be acquired during the next half-hour, but without any additional injections.

Trial Locations (1)

21204

Baltimore Medical & Surgical Associates PA, Towson

All Listed Sponsors
collaborator

Baltimore Medical & Surgical Associates PA

UNKNOWN

lead

University of Maryland, Baltimore

OTHER

NCT02978560 - Indocyanine Green Tissue Perfusion Monitoring | Biotech Hunter | Biotech Hunter